EP3923940
PHARMACEUTICAL COMBINATION COMPRISING TNO155 AND A PD-1 INHIBITOR
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
10.2.2020EP published:
3.12.2025EP application number:
20707826.2
EPO information:
European Patent Register
Max expiry date:
9.2.2040
Title in English:
PHARMACEUTICAL COMBINATION COMPRISING TNO155 AND A PD-1 INHIBITORLanguage of the patent:
English
Timeline
Today
10.2.2020EP application
3.12.2025EP Publication
Owner
Name:
Novartis AGAddress:
Lichtstrasse 35, 4056 Basel, CH
Inventor
Name:
CHEN, Ying-nan PanAddress:
Wilmington, Delaware 19808, US
Name:
HAO, HuaixiangAddress:
Cambridge, Massachusetts 02139, US
Name:
LIU, ChenAddress:
Cambridge, Massachusetts 02139, US
Name:
MOHSENI, MorvaridAddress:
Cambridge, Massachusetts 02139, US
Name:
HASTINGS, William D.Address:
Cambridge, MA 02139, US
Name:
GOLDONI, SilviaAddress:
Winchester, MA 01890, US
Priority
Number:
201962804707 PDate:
12.2.2019Country:
US
Classification
Categories:
A61K 31/497, A61K 45/06, A61P 35/00